AQR Capital Management’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-65,966
| Closed | -$3.13M | – | 3565 |
|
|
2025
Q3 | $3.13M | Buy |
65,966
+32,219
| +95% | +$1.56M | ﹤0.01% | 1717 |
|
|
2025
Q2 | $1.8M | Buy |
33,747
+27,984
| +486% | +$1.27M | ﹤0.01% | 1845 |
|
|
2025
Q1 | $233K | Sell |
5,763
-2,889
| -33% | -$122K | ﹤0.01% | 2811 |
|
|
2024
Q4 | $241K | Buy |
+8,652
| New | +$262K | ﹤0.01% | 2596 |
|
|
2024
Q1 | – | Sell |
-16,767
| Closed | -$392K | – | 2406 |
|
|
2023
Q4 | $392K | Buy |
16,767
+5,868
| +54% | +$116K | ﹤0.01% | 1978 |
|
|
2023
Q3 | $551K | Sell |
10,899
-7,135
| -40% | -$332K | ﹤0.01% | 1820 |
|
|
2023
Q2 | $842K | Sell |
18,034
-11,962
| -40% | -$548K | ﹤0.01% | 1624 |
|
|
2023
Q1 | $1.15M | Buy |
29,996
+16,313
| +119% | +$727K | ﹤0.01% | 1491 |
|
|
2022
Q4 | $750K | Buy |
+13,683
| New | +$586K | ﹤0.01% | 1656 |
|
